| 188Re标记物治疗肝细胞性肝癌的研究进展 |
| |
| 引用本文： | 李依明,王杰,程旭,曹莉明. 188Re标记物治疗肝细胞性肝癌的研究进展[J]. 介入放射学杂志, 2012, 21(7): 611-613 |
| |
| 作者姓名： | 李依明 王杰 程旭 曹莉明 |
| |
| 作者单位： | 1. 南京医科大学第一附属医院放射介入科,南京,210029
2. 南京医科大学第一附属医院核医学科,南京,210029 |
| |
| 摘 要： | 近年来,188Re标记的放射性药物成为治疗肝细胞性肝癌的讨论热点之一。逐渐增多的研究表明其治疗肝细胞性肝癌具有安全性和有效性,是一种有前景治疗用放射性核素。本文就188Re物理特性及其标记物在治疗肝细胞性肝癌的动物实验研究、临床研究及放射性防护等方面的新进展进行总结。
|
| 关 键 词： | 铼-188 肝细胞性肝癌 核素 |
Rhenium-188 based radiopharmaceuticals for the treatment of hepatocellular carcinomas: its recent progress in research |
| |
| LI Yi-ming , WANG Jie , CHENG Xu , CAO Li-ming. Rhenium-188 based radiopharmaceuticals for the treatment of hepatocellular carcinomas: its recent progress in research[J]. Journal of Interventional Radiology, 2012, 21(7): 611-613 |
| |
| Authors: | LI Yi-ming WANG Jie CHENG Xu CAO Li-ming |
| |
| Affiliation: | .Dapartment of Interventional Radiology,the First Affiliated Hospital of Nanjing Medical University,Nanjing 210029,China |
| |
| Abstract: | For recent years,the discussion about the rhenium-188 based radiopharmaceuticals has become a hot subject concerning the treatment of hepatocellular carcinomas(HCCs).Numerous researches have indicated that rhenium -188 based radiopharmaceuticals can be safely and effectively employed in the treatment of HCCs.This paper aims to introduce the physical properties of Rhenium-188 and to summarize the recent research progress in treating inoperable HCCs with Rhenium-188,both in clinical and experimental studies,as well as in the radioactive prevention. |
| |
| Keywords: | rhenium-188 hepatocellular carcinoma nuclide |
| 本文献已被 CNKI 万方数据 等数据库收录！ |
|
